Chong Zhang

3.5k total citations · 1 hit paper
128 papers, 2.6k citations indexed

About

Chong Zhang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Chong Zhang has authored 128 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 39 papers in Pulmonary and Respiratory Medicine and 29 papers in Oncology. Recurrent topics in Chong Zhang's work include Cancer therapeutics and mechanisms (14 papers), Lung Cancer Treatments and Mutations (14 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Chong Zhang is often cited by papers focused on Cancer therapeutics and mechanisms (14 papers), Lung Cancer Treatments and Mutations (14 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Chong Zhang collaborates with scholars based in China, United States and Bangladesh. Chong Zhang's co-authors include Lei Zhang, Feng Xie, Haiyan Yan, Fangfang Zhou, Xiaoxue Zhou, Lei Zhao, Long Zhang, Jun Chen, Jun Huang and Lin‐wen Wu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Chong Zhang

119 papers receiving 2.5k citations

Hit Papers

Ferroptosis in cancer and cancer immunotherapy 2022 2026 2023 2024 2022 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chong Zhang China 26 1.2k 837 477 376 268 128 2.6k
Hans Adomat Canada 27 1.5k 1.2× 1.2k 1.4× 915 1.9× 461 1.2× 92 0.3× 94 3.1k
Ramesh Narayanan United States 31 1.2k 1.0× 703 0.8× 360 0.8× 476 1.3× 164 0.6× 84 2.7k
Alice C. Levine United States 33 1.5k 1.2× 814 1.0× 808 1.7× 595 1.6× 126 0.5× 79 3.9k
Da Duan China 19 2.2k 1.8× 376 0.4× 579 1.2× 248 0.7× 139 0.5× 39 3.0k
P. Ghosh United States 34 2.1k 1.7× 1.0k 1.2× 678 1.4× 726 1.9× 80 0.3× 135 3.7k
Xin Wang China 26 1.0k 0.8× 556 0.7× 487 1.0× 643 1.7× 69 0.3× 227 2.9k
Xiao‐Feng Zhu China 26 1.4k 1.1× 536 0.6× 624 1.3× 426 1.1× 122 0.5× 105 2.5k
Lin Lv China 25 840 0.7× 373 0.4× 405 0.8× 567 1.5× 126 0.5× 68 2.1k
Mauro Bologna Italy 36 1.7k 1.4× 789 0.9× 722 1.5× 1.1k 2.9× 184 0.7× 116 3.5k
Pierre Hardy Canada 37 1.5k 1.2× 455 0.5× 408 0.9× 156 0.4× 185 0.7× 111 3.8k

Countries citing papers authored by Chong Zhang

Since Specialization
Citations

This map shows the geographic impact of Chong Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong Zhang more than expected).

Fields of papers citing papers by Chong Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chong Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong Zhang. The network helps show where Chong Zhang may publish in the future.

Co-authorship network of co-authors of Chong Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Chong Zhang. A scholar is included among the top collaborators of Chong Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chong Zhang. Chong Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Lixin, Xiao-Li Zheng, Yu Cao, et al.. (2025). Development of novel epoxyketone macrocyclic peptidyl proteasome inhibitors through OPA-mediated one-step cyclization of unprotected peptides. Bioorganic Chemistry. 156. 108180–108180.
2.
Zhang, Tianhao, Chong Zhang, Jie Li, et al.. (2025). Proton shuttle mediated by ionic liquid promotes aldol condensation. Journal of Catalysis. 444. 116001–116001.
4.
Zhang, Chong, et al.. (2024). TSPAN6 reinforces the malignant progression of glioblastoma via interacting with CDK5RAP3 and regulating STAT3 signaling pathway. International Journal of Biological Sciences. 20(7). 2440–2453. 3 indexed citations
5.
Zhang, Chong, et al.. (2024). Blocking β2-AR and Inhibiting COX-2: A Promising Approach to Suppress OSCC Development. International Dental Journal. 75(2). 807–816. 3 indexed citations
7.
Han, Rui, Caiyu Lin, Chong Zhang, et al.. (2023). The potential therapeutic regimen for overcoming resistance to osimertinib due to rare mutations in NSCLC. iScience. 26(7). 107105–107105. 4 indexed citations
9.
Xu, Lin, Lin‐wen Wu, Jun Deng, et al.. (2023). DSCC1 interacts with HSP90AB1 and promotes the progression of lung adenocarcinoma via regulating ER stress. Cancer Cell International. 23(1). 208–208. 9 indexed citations
10.
Zhang, Jiankang, Zheng Wang, Jie Li, et al.. (2023). Triacanthine enhances the sensitivity of colorectal cancer cells to 5-fluorouracil by regulating RRM2. Phytomedicine. 126. 155204–155204.
11.
Zhao, Lei, Xiaoxue Zhou, Feng Xie, et al.. (2022). Ferroptosis in cancer and cancer immunotherapy. Cancer Communications. 42(2). 88–116. 457 indexed citations breakdown →
13.
Han, Rui, Shuai Hao, Conghua Lu, et al.. (2020). Aspirin sensitizes osimertinib‐resistant NSCLC cells in vitro and in vivo via Bim‐dependent apoptosis induction. Molecular Oncology. 14(6). 1152–1169. 26 indexed citations
14.
Li, Yang-ling, et al.. (2020). ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3. Oncogene. 39(39). 6203–6217. 65 indexed citations
15.
Zeng, Linghui, et al.. (2019). <p>High-dose vitamin C suppresses the invasion and metastasis of breast cancer cells via inhibiting epithelial-mesenchymal transition</p>. OncoTargets and Therapy. Volume 12. 7405–7413. 31 indexed citations
16.
Zhang, Chong, et al.. (2017). Chondromatous hamartoma of cervical esophagus: a case report and literature review. Journal of Thoracic Disease. 9(3). E236–E244. 2 indexed citations
17.
Wang, Yanxiao, Ning Hou, Xuan Cheng, et al.. (2017). Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma. International Journal of Biological Sciences. 13(5). 652–659. 45 indexed citations
18.
Yu, Xiaolin, Jianbao Zhang, Dongdong Xie, Jue Wang, & Chong Zhang. (2009). Relationship between scalp potential and autonomic nervous activity during a mental arithmetic task. Autonomic Neuroscience. 146(1-2). 81–86. 55 indexed citations
19.
Xu, Guiqing, Chong Zhang, Lei Zhang, et al.. (2008). Synthesis, Cytotoxicity and Protein Kinase C Inhibition of Arylpyrrolylmaleimides. Archiv der Pharmazie. 341(5). 273–280. 6 indexed citations
20.
Zhang, Chong, et al.. (2007). Rare fibrosing granulomatous mediastinitis of tuberculosis with involvement of the transverse sinus. Journal of Thoracic and Cardiovascular Surgery. 133(3). 836–837. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026